These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33450)

  • 1. [Bucco-linquo-facial and choriform hyperkinesies (author's transl)].
    Trillet M; Laurent B
    Sem Hop; 1978 Nov 8-15; 54(37-40):1159-63. PubMed ID: 33450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Senile dyskinesias and tardive dyskinesias].
    Brion S; Plas J; Chevalier JF; Dussaux P
    Encephale; 1988 Sep; 14 Spec No():215-9. PubMed ID: 2905649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroleptic-induced movement disorders: historical perspectives].
    Wolf MA; Yassa R; Llorca PM
    Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Abnormal involuntary movements in the elderly and their treatment (author's transl)].
    Delwaide PJ; Desseilles M
    Sem Hop; 1978 Nov 18-25; 54(41-42):1247-9. PubMed ID: 32624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical aspects of tardive dyskinesias induced by neuroleptics].
    Villeneuve A; Lajeunesse C
    Encephale; 1988 Sep; 14 Spec No():209-14. PubMed ID: 2905648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controlled therapeutic study of spontaneous bucco-linguo-facial dyskinesias (author's transl)].
    Delwaide PJ; Desseilles M
    Sem Hop; 1979 Oct 18-25; 55(35-36):1585-9. PubMed ID: 44015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and diagnosis of tardive dyskinesia.
    Klawans HL
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):3-7. PubMed ID: 2858477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallels between neuroleptic effects and lethargic encephalitis: the production of dyskinesias and cognitive disorders.
    Breggin PR
    Brain Cogn; 1993 Sep; 23(1):8-27. PubMed ID: 8105824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tardive dyskinesia. A possible complication of chronic treatment with neuroleptics].
    D'Aquila F; Rampello L
    Riv Neurol; 1990; 60(4):140-5. PubMed ID: 1982720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Orofacial dyskinesia. A current pathology].
    Gaillard-Perera H; Gaillard A
    Rev Stomatol Chir Maxillofac; 1992; 93(5):327-32. PubMed ID: 1411232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral dyskinesis, facial dystonia].
    Nakamura S; Akiguchi I
    Nihon Rinsho; 1993 Nov; 51(11):2978-82. PubMed ID: 8277580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tardive dyskinesia induced by neuroleptics. A review of the literature].
    Diepart E; Cottereau MJ; Deniker P
    Encephale; 1979; 5(4):317-37. PubMed ID: 42528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Movement disorders with neuroleptic drug treatment.
    Tarsy D
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tardive dyskinesia].
    Sabbatini F; Gentile S; De Mattei M; Pinessi L; Rainero I
    Minerva Med; 1985 Apr; 76(16):797-802. PubMed ID: 2860619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involuntary movement disorders--each has a meaning all its own.
    Kramer J; Klawans HL
    Geriatrics; 1979 Sep; 34(9):63-71. PubMed ID: 38189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Historical perspective on movement disorders.
    Friedman JH
    J Clin Psychiatry; 2004; 65 Suppl 9():3-8. PubMed ID: 15189105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facial dyskinesias.
    Kaufman DM
    Psychosomatics; 1989; 30(3):263-9. PubMed ID: 2669010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of dyskinesias with tiapride (author's transl)].
    Kocher R; Hobi V
    Sem Hop; 1980 Dec 18-25; 56(47-68):2033-4. PubMed ID: 6109379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment.
    Crossman AR
    Mov Disord; 1990; 5(2):100-8. PubMed ID: 1970120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of tardive dyskinesia.
    Kulkarni SK; Dhir A
    Int Rev Neurobiol; 2011; 98():265-87. PubMed ID: 21907091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.